Consensus statement on the use of clozapine during the COVID-19 pandemic

Dan Siskind; William G Honer; Scott Clark; Christoph U Correll; Alkomiet Hasan; Oliver Howes; John M Kane; Deanna L Kelly; Robert Laitman; Jimmy Lee; James H MacCabe; Nick Myles; Jimmi Nielsen; Peter F Schulte; David Taylor; Helene Verdoux; Amanda Wheeler; Oliver Freudenreich

doi:10.1503/jpn.200061

Consensus statement on the use of clozapine during the COVID-19 pandemic

Dan Siskind, William G Honer, Scott Clark, Christoph U Correll, Alkomiet Hasan, Oliver Howes, John M Kane, Deanna L Kelly, Robert Laitman, Jimmy Lee, James H MacCabe, Nick Myles, Jimmi Nielsen, Peter F Schulte, David Taylor, Helene Verdoux, Amanda Wheeler, Oliver Freudenreich

Psykiatrisk Center Glostrup

118 Citations (Scopus)

Original language	English
Journal	Journal of psychiatry & neuroscience : JPN
Volume	45
Issue number	3
Pages (from-to)	222-223
Number of pages	2
ISSN	1180-4882
DOIs	https://doi.org/10.1503/jpn.200061
Publication status	Published - 1 May 2020

Keywords

Antipsychotic Agents/adverse effects
Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Clozapine/adverse effects
Consensus
Coronavirus Infections/blood
Humans
Neutropenia/chemically induced
Pandemics
Pneumonia, Viral/blood
SARS-CoV-2
Schizophrenia/blood

Access to Document

10.1503/jpn.200061

Cite this

Siskind, D., Honer, W. G., Clark, S., Correll, C. U., Hasan, A., Howes, O., Kane, J. M., Kelly, D. L., Laitman, R., Lee, J., MacCabe, J. H., Myles, N., Nielsen, J., Schulte, P. F., Taylor, D., Verdoux, H., Wheeler, A., & Freudenreich, O. (2020). Consensus statement on the use of clozapine during the COVID-19 pandemic. Journal of psychiatry & neuroscience : JPN, 45(3), 222-223. https://doi.org/10.1503/jpn.200061

Siskind, D, Honer, WG, Clark, S, Correll, CU, Hasan, A, Howes, O, Kane, JM, Kelly, DL, Laitman, R, Lee, J, MacCabe, JH, Myles, N, Nielsen, J, Schulte, PF, Taylor, D, Verdoux, H, Wheeler, A & Freudenreich, O 2020, 'Consensus statement on the use of clozapine during the COVID-19 pandemic', Journal of psychiatry & neuroscience : JPN, vol. 45, no. 3, pp. 222-223. https://doi.org/10.1503/jpn.200061

@article{4d2598ccbe0c4a7483f14ee0e3e094b9,

title = "Consensus statement on the use of clozapine during the COVID-19 pandemic",

keywords = "Antipsychotic Agents/adverse effects, Betacoronavirus, COVID-19, COVID-19 Testing, Clinical Laboratory Techniques, Clozapine/adverse effects, Consensus, Coronavirus Infections/blood, Humans, Neutropenia/chemically induced, Pandemics, Pneumonia, Viral/blood, SARS-CoV-2, Schizophrenia/blood",

author = "Dan Siskind and Honer, {William G} and Scott Clark and Correll, {Christoph U} and Alkomiet Hasan and Oliver Howes and Kane, {John M} and Kelly, {Deanna L} and Robert Laitman and Jimmy Lee and MacCabe, {James H} and Nick Myles and Jimmi Nielsen and Schulte, {Peter F} and David Taylor and Helene Verdoux and Amanda Wheeler and Oliver Freudenreich",

year = "2020",

month = may,

day = "1",

doi = "10.1503/jpn.200061",

language = "English",

volume = "45",

pages = "222--223",

journal = "Journal of psychiatry & neuroscience : JPN",

issn = "1180-4882",

publisher = "Canadian Medical Association",

number = "3",

}

TY - JOUR

T1 - Consensus statement on the use of clozapine during the COVID-19 pandemic

AU - Siskind, Dan

AU - Honer, William G

AU - Clark, Scott

AU - Correll, Christoph U

AU - Hasan, Alkomiet

AU - Howes, Oliver

AU - Kane, John M

AU - Kelly, Deanna L

AU - Laitman, Robert

AU - Lee, Jimmy

AU - MacCabe, James H

AU - Myles, Nick

AU - Nielsen, Jimmi

AU - Schulte, Peter F

AU - Taylor, David

AU - Verdoux, Helene

AU - Wheeler, Amanda

AU - Freudenreich, Oliver

PY - 2020/5/1

Y1 - 2020/5/1

KW - Antipsychotic Agents/adverse effects

KW - Betacoronavirus

KW - COVID-19

KW - COVID-19 Testing

KW - Clinical Laboratory Techniques

KW - Clozapine/adverse effects

KW - Consensus

KW - Coronavirus Infections/blood

KW - Humans

KW - Neutropenia/chemically induced

KW - Pandemics

KW - Pneumonia, Viral/blood

KW - SARS-CoV-2

KW - Schizophrenia/blood

UR - http://www.scopus.com/inward/record.url?scp=85083188654&partnerID=8YFLogxK

U2 - 10.1503/jpn.200061

DO - 10.1503/jpn.200061

M3 - Editorial

C2 - 32297722

SN - 1180-4882

VL - 45

SP - 222

EP - 223

JO - Journal of psychiatry & neuroscience : JPN

JF - Journal of psychiatry & neuroscience : JPN

IS - 3

ER -

Consensus statement on the use of clozapine during the COVID-19 pandemic

Keywords

Access to Document

Other files and links

Cite this